KME-2780 is the orally active inhibitor for IRAK1 and IRAK4 with IC50s of 19 nM and 0.5 nM. KME-2780 can be used for research of dysregulation of innate immune signaling and hematologic malignancies[1].
Molecular Weight:
333.43
Purity:
98.94
CAS Number:
[2968466-26-2]
Formula:
C20H23N5
Target:
Apoptosis,IRAK
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted